Plasma and urine disposition of 1-a-acetyimethadol and its principal metabolites in man

Journal of Analytical Toxicology

Volumn 6, Issue 2, 1982, Pages 100-105

  Finkl, Bryan S ^a   Jennison, Thomas A ^a   Chinn, Dennis M ^a   Ling, Walter ^b   Holmes, Elaine D ^b  

^a UNIVERSITY OF UTAH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLMETHADOL; ACETYLMETHADOL C 14; RADIOISOTOPE; UNCLASSIFIED DRUG;

ARTICLE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG URINE LEVEL; GAS CHROMATOGRAPHY; HUMAN CELL; MASS SPECTROMETRY; NORMAL HUMAN; PHARMACOKINETICS; PLASMA; URINE;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; HALF-LIFE; HUMANS; MALE; METHADONE; METHADYL ACETATE;

EID: 0020048420     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/6.2.100     Document Type: Article

References (20)

1. K.K. Chen. Pharmacology of methadone and related compounds. Ann. N.Y. Acad. Sci. 51:83-97 (1948).
2. A. Keats and H. Beecher. Analgesic activity and toxic effects of acetylmethadol isomers in man. J. Pharmacol. Exp. Ther. 18:92-103(1952).
3. H.F. Fraser and H. Isbell. Actions and addition liabilities of alpha-acetylmethadol in man. J. Pharmacol. Exp. Ther. 105: 210(1952).
4. J.H. Jaffe, C. Schuster, B. Smith, and P. Blachly. Comparison of acetylmethadol and methadone in the treatment of longterm heroin users. J.A.M.A. 211:1834-36 (1970).
5. C.Y. Sung and E.L. Way. The fate of the optical isomers of alpha-acetylmethadol. J. Pharmacol. Exp. Ther. 110:260-70 (1954).
6. R E. Mc Mahon, H.W. Culp, and F.J. Marshall. The metabolism of 1-a-acetylmethadol in the rat: The identification of the probable active metabolite. J. Pharmacol. Exp. Ther. 149: 436-45(1965).
7. R.E. Billings, R. Booher, S. Smits, A Portland, and R.E. Mc Mahon. Metabolism of acetylmethadol in the rat. A sensitive assay for nor-acetylmethadol and the identification of a new active metabolite. J. Med. Chem. 16:305-06 (1973).
8. H. North-Root, S.H. Huttab, and G.L. Henderson. Biological disposition of transformation of 1-a-acetylmethadol in the monkey, dog and rat. Proc. Natl. Res. Council, Natl. Acad, of Sci. Comm, on Problems of Drug Dependence, 1975, pp 645-57.
9. G.L. Henderson. Biological fate of 3H-LAAM in rat, dog and monkeys. Proc. Natl. Drug Abuse Conf., New York, March, 1976.
10. A.L. Misra, J. Vardy, and R. Bloch. Pharmacokinetics and metabolism of (3H)-LAAM in the mouse and disposition of (3H)-naltrexone in the CNS of the rat. Proc. Nat'l Drug Abuse Conf., New York, March, 1976.
11. R.E. Billings, R.E. Mc Mahon, and D.A. Blake. 1-Acetyl-methadol (LAAM) treatment of opiate dependence: Plasma and urine levels of two pharmacologically active metabolites. Life Sci. 14:1437-46 (1974).
12. R.F. Kaiko and C.E. Inturrisi. Disposition of acetylmethadol in relation to pharmacological activity. Clin. Pharmacol. Ther. 18:96-103 (1975).
13. G.L. Henderson, A.J. Weinberg, W.A. Hargreaves, D.H.M. Lau, J. Tyler, and B. Baker. Accumulation of 1-a-acetylme-thadol (LAAM) and active metabolites in plasma following chronic administration. J. Anal. Toxicol. 1:1-5 (1977).
14. T.A. Jennison, B.S. Finkle, D.M. Chinn, and D.J. Crouch. The quantitative analysis of 1-cr-acetylmethadol and its principal metabolites in biological specimens by gas-chromatography-chemical ionization-multiple ion monitoring mass spectrometry. J. Chromatogr. Sci. 17:64-74 (1979).
15. R.E. Mc Mahon, A.S. Ridolfo, H.W. Calp, P.L. Wolen, and F.J. Marshall. The fate of radiocarbon-labelled propoxyphene in rat, dog and human. Toxicol. Appl. Pharmacol. 19: 427-44 (1971).
16. G.L. Henderson, B.K. Wilson, and D.H.M. Lau. Plasma 1-a-acetylmethadol (LAAM) after acute and chronic administration. Clin. Pharmacol. Ther. 21:16-25 (1976).
17. D. Perrier and M. Gibaldi. Influence of first pass effect on systemic availability of propoxyphene. J. Clin. Pharmacol. 12: 449-52 (1972).
18. M.K. Buening and M.R. Franklin. SKF525-A inhibition, induction and 455 nm complex formation. Drug Metab. Dispos. 4: 244-55(1976).
19. S.M. Roberts and M.R. Franklin. Propoxyphene and in vivo formation of cytochrome P-450 metabolic intermediate (Ml) complexes. The Pharmacologist. 19:210 (1976).
20. M.R. Franklin and S.M. Roberts. The cytochrome P-450 dependent metabolism of drugs of possible use in opiate addiction treatment programs. Fed. Proc. 36:940 (1977).